Internal Medicine, Allergy & Immunology · Williamsville, NY
NPI
1811919988
Since 2006
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
400 International Dr
Williamsville, NY, 14221
Phone (716) 631-3555
Groups this clinician bills Medicare through
Medicare paid, 2024
$81K
6,165 services
Medicare patients, 2024
186
Average age 62
Drug cost, 2024
$3.2M
5,386 prescriptions
Company payments, 2025
$1,680
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julian Ambrus Jr. was code J3480 (injection, potassium chloride, per 2 meq), 2,777 times for 22 patients. In total Julian Ambrus Jr. billed 6,165 services in 28 codes, and Medicare paid $81K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3480 Injection, potassium chloride, per 2 meq | Office | 2,777 | 22 | $0.08 | $235 |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 1,155 | 22 | $0.44 | $511 |
| J7042 5% dextrose/normal saline (500 ml = 1 unit) | Office | 618 | 20 | $0.96 | $593 |
| 96365 Intravenous Infusion, Hydration | Office | 598 | 25 | $44.77 | $27K |
| 99214 Office E&M - Established | Office | 285 | 132 | $75.80 | $22K |
| J7030 Infusion, normal saline solution , 1000 cc | Office | 279 | 15 | $2.00 | $558 |
| 99215 Office E&M - Established | Office | 248 | 117 | $114.01 | $28K |
| 99443 Telephone Services | Office | 13 | 13 | $39.73 | $516 |
By year: 2022 $83K for 4,716 services; 2023 $83K for 5,711 services; 2024 $81K for 6,165 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 17 | 16 | $8.40 | $143 |
Medicare prescription drug claims, 2024
In 2024, the drug Julian Ambrus Jr. prescribed most often to Medicare patients was Levocarnitine, with 657 prescriptions and refills. In total Julian Ambrus Jr. wrote 5,386 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocarnitine Generic | 657 | 953 | 169 | $60K |
| Hydroxychloroquine Sulfate Generic | 285 | 411 | 58 | $11K |
| Azelastine Hcl Generic | 202 | 315 | 84 | $8,712 |
| Cevimeline Hcl Generic | 177 | 268 | 41 | $34K |
| Folic Acid Generic | 171 | 247 | 39 | $2,365 |
| Verapamil Hcl Generic | 163 | 243 | 54 | $2,211 |
| Cyproheptadine Hcl Generic | 148 | 168 | 30 | $3,914 |
| Nimodipine Generic | 135 | 192 | 47 | $41K |
| Fluticasone Propionate Generic | 129 | 172 | 38 | $1,871 |
| Meloxicam Generic | 121 | 172 | 32 | $788 |
| Cilostazol Generic | 109 | 185 | 31 | $2,209 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 98 | 98 | Under 11 | $864K |
| Diphenhydramine Hcl Generic | 84 | 92 | Under 11 | $4,612 |
| Levocetirizine Dihydrochloride Generic | 80 | 120 | 18 | $1,168 |
| Doxazosin Mesylate Generic | 77 | 115 | 20 | $1,233 |
Brand drugs: - claims; generic drugs: 4,702 claims; opioid claims: 59.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julian Ambrus Jr. $1,680 ($1,680 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $322.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 15 | $322 |
| Amgen Inc. AMGN | 12 | $226 |
| BioCryst US Sales Co., LLC | 10 | $185 |
| UCB, Inc. UCB.BR | 6 | $144 |
| Regeneron Healthcare Solutions, Inc. REGN | 5 | $102 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $80.63 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $71.28 |
| Exact Sciences Corporation EXAS | 3 | $61.84 |
| Genzyme Corporation SNY | 3 | $54.8 |
| Janssen Biotech, Inc. JNJ | 3 | $53.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.